logo
Should You Think About Buying FTAI Aviation Ltd. (NASDAQ:FTAI) Now?

Should You Think About Buying FTAI Aviation Ltd. (NASDAQ:FTAI) Now?

Yahoo29-05-2025

Let's talk about the popular FTAI Aviation Ltd. (NASDAQ:FTAI). The company's shares saw a significant share price rise of 36% in the past couple of months on the NASDAQGS. While good news for shareholders, the company has traded much higher in the past year. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, what if the stock is still a bargain? Today we will analyse the most recent data on FTAI Aviation's outlook and valuation to see if the opportunity still exists.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
According to our valuation model, FTAI Aviation seems to be fairly priced at around 9.73% above our intrinsic value, which means if you buy FTAI Aviation today, you'd be paying a relatively reasonable price for it. And if you believe that the stock is really worth $107.75, then there isn't really any room for the share price grow beyond what it's currently trading. Although, there may be an opportunity to buy in the future. This is because FTAI Aviation's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.
Check out our latest analysis for FTAI Aviation
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. FTAI Aviation's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.
Are you a shareholder? It seems like the market has already priced in FTAI's positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven't considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?
Are you a potential investor? If you've been keeping an eye on FTAI, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it's worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
If you want to dive deeper into FTAI Aviation, you'd also look into what risks it is currently facing. For instance, we've identified 4 warning signs for FTAI Aviation (1 is a bit concerning) you should be familiar with.
If you are no longer interested in FTAI Aviation, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One
The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Yahoo

time17 minutes ago

  • Yahoo

The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One

Omada Health (NASDAQ:OMDA) opened its first day of trading with a bangjumping 21% to $23 after pricing its IPO at $19. That move gives the digital chronic-care startup a market cap of roughly $1.3 billion. The $150 million raise was more than just well receivedinvestor demand came in more than 15x oversubscribed, with most allocations going to a concentrated group of institutional buyers. It's another sign that appetite for health-tech IPOs is heating up again. U.S. listings have raised nearly $25 billion year-to-date, and early-stage healthcare names are up an average of 18% since listing. Founded in 2011, Omada offers virtual care between doctor visitsfocused on diabetes, obesity, hypertension, and joint pain. What sets it apart? It's not chasing the GLP-1 gold rush. Instead, Omada supports people already on those drugs, helping them manage side effects, nutrition, and post-treatment maintenance. About 50,000 of its 679,000 members are on GLP-1s. CEO Sean Duffy told Bloomberg that while AI powers much of the back-end, real human interaction is what drives results. Our members tell us they want a personand I have yet to see anyone that feels accountable to ChatGPT, he said. Revenue for Q1 2025 came in just under $55 millionup from $35.1 million a year agowhile net losses narrowed by more than half to $9.4 million. That improving financial picture, combined with a clear niche in chronic care, could be what's drawing top-tier investors. Revelation Partners, Andreessen Horowitz, Fidelity, and USVP are all among the largest shareholders. The IPO was led by Morgan Stanley, Goldman Sachs, and JPMorgan. OMDA now trades on the Nasdaq Global Marketand it's one more sign that digital health might be staging a real comeback. This article first appeared on GuruFocus.

Gemini now lets you schedule tasks ahead of time
Gemini now lets you schedule tasks ahead of time

Android Authority

time18 minutes ago

  • Android Authority

Gemini now lets you schedule tasks ahead of time

Ryan Haines / Android Authority TL;DR Gemini now lets you automate routine tasks with its new scheduled actions feature. You can use it to schedule prompts to perform a task at a specific time, day, date, or after an event. The feature is available in the Gemini app for users with a Google AI Pro or Ultra subscription and qualifying Google Workspace business and education plans. Google has started rolling out Gemini's scheduled actions feature, which we spotted in a teardown earlier this year. As highlighted in the code strings, the feature allows users to automate routine tasks, similar to the scheduled tasks feature already available in ChatGPT. The scheduled actions feature will be available in the Gemini app starting today. Google says it will let users schedule prompts to perform tasks at a later date, time, or after an event. Users can utilize the feature to automate tasks like getting a summary of their calendar and unread emails every morning, generating five ideas for their blog every Monday, or staying updated on their favorite sports team. In addition to being useful for routine tasks, Gemini's scheduled actions will also come in handy for one-off tasks like getting a summary of an award show the day after it happens. Google adds that Gemini will allow users to transform prompts they're already using into recurring actions or manage existing actions within the new scheduled actions page in settings. Sadly, the scheduled actions feature isn't available for all Gemini users. It is limited to users with a Google AI Pro or Ultra subscription and qualifying Google Workspace business and education plans. Google may eventually make the feature available on Gemini's free tier, but there's no official confirmation yet. Got a tip? Talk to us! Email our staff at Email our staff at news@ . You can stay anonymous or get credit for the info, it's your choice.

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO
Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Yahoo

time22 minutes ago

  • Yahoo

Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO

Omada Health (OMDA, Financials) surged 42% in its Nasdaq debut Friday after the virtual chronic care company priced its initial public offering at $19 per share, raising $150 million and securing a valuation just above $1 billion. The stock opened at $23 and climbed quickly past $27. Warning! GuruFocus has detected 8 Warning Sign with X. Founded in 2012, Omada offers virtual programs for chronic conditions including prediabetes, diabetes, and hypertension. The IPO, which sold 7.9 million shares, is part of a recent resurgence in health and tech listings, following last month's debut of Hinge Health and Thursday's surge in Circle Internet shares. In its prospectus, Omada reported Q1 revenue jumped 57% year over year to $55 million, while full-year 2024 revenue rose 38% to $169.8 million. The company narrowed its net loss in the most recent quarter to $9.4 million from $19 million a year earlier. Major outside shareholders include U.S. Venture Partners, Andreessen Horowitz, and Fidelity's FMR LLC, each holding a 9% to 10% stake. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store